Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

June 17, 2004

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

June 17, 2004

Sosei's phase I trial of SOU-001 cleared to begin in U.K.

June 17, 2004

FDA accepts IND for stem cell mobilizing drug CTCE-0214

June 17, 2004

Crucell enters PER.C6 licensing agreement with Chiron

June 17, 2004

Positive preliminary phase III results for Sativex in neuropathic pain

June 17, 2004

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

June 17, 2004

An EGF vaccine reported to improve survival in advanced lung cancer

June 17, 2004

Study results on GLP-1 analogue CJC-1131 presented during ADA

June 17, 2004

Novel potent and selective 5-HT2C agonists for the treatment of obesity discovered at Wyeth

June 17, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...